Evidence map›Paper›PMID 41832929›Full record

Trial reportEuropean radiology2026

Should AI results be disclosed in mammography reports? A randomised survey study of patient responses to concordant and discordant interpretations.

Filippo Pesapane, Catherine Depretto, Anna Rotili, Silvia Penco, Dario Monzani, Roberto Grasso, Luca Nicosia, Carmen Mallardi, Lucrezia D'Amelio, Serena Carriero and 6 more

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Filippo PesapaneBreast Imaging Division, Radiology Department, IEO European Institute of Oncology IRCCS, Milan, Italy. filippo.pesapane@ieo.it.ORCID http://orcid.org/0000-0002-0374-5054
Catherine DeprettoBreast Radiology Unit, Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Anna RotiliBreast Imaging Division, Radiology Department, IEO European Institute of Oncology IRCCS, Milan, Italy.
Silvia PencoBreast Imaging Division, Radiology Department, IEO European Institute of Oncology IRCCS, Milan, Italy.
Dario MonzaniApplied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology IRCCS, Milan, Italy.
Roberto GrassoApplied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology IRCCS, Milan, Italy.
Luca NicosiaBreast Imaging Division, Radiology Department, IEO European Institute of Oncology IRCCS, Milan, Italy.
Carmen MallardiBreast Imaging Division, Radiology Department, IEO European Institute of Oncology IRCCS, Milan, Italy.
Lucrezia D'AmelioDepartment of Medical Surgical Sciences and Translational Medicine, Sapienza University of Rome, Radiology Unit, Sant'Andrea University Hospital, Rome, Italy.
Serena CarrieroBreast Imaging Division, Radiology Department, Foundation IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Giovanni IrmiciBreast Radiology Unit, Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Gianmarco Della PepaBreast Radiology Unit, Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Gabriella PravettoniApplied Research Division for Cognitive and Psychological Science, IEO European Institute of Oncology IRCCS, Milan, Italy.
Sonia SanticchiaBreast Imaging Division, Radiology Department, Foundation IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Gianfranco ScaperrottaBreast Radiology Unit, Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Enrico CassanoBreast Imaging Division, Radiology Department, IEO European Institute of Oncology IRCCS, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess how disclosing artificial intelligence (AI) results, particularly discordant findings, affects patient trust, anxiety, follow-up intentions, and attitudes toward AI in mammography. The study also assessed whether adding an explanatory note mitigates adverse reactions. MATERIALS AND

methodsA cross-sectional randomised experimental survey was conducted among 600 women (mean age 55.4 ± 6.8 years) undergoing mammography in two academic centres in Milan, Italy, between January 2023 and January 2024. Participants were randomised into four hypothetical BI-RADS 1 scenarios: Radiologist Only (control), AI No-Flag (AI concordant with radiologist), AI Flagged (AI discordant false-positive), and AI Flagged + Explanation (discordant AI with contextual information). Primary outcomes included trust (0-100 scale), worry, second-opinion intent, legal action intent, and AI approval. Analyses involved ANOVA, chi-square tests, and logistic regression with Bonferroni correction.

resultsDisclosure of a discordant AI result significantly reduced trust in the radiologist (73.0 vs 90.1; p < 0.001), and increased anxiety (58.0% vs 16.0%; OR = 15.4), second-opinion intent (50.0% vs 8.7%; OR = 10.2), and legal action consideration (60.7% vs 38.7%; OR = 2.49). Adding explanatory context significantly mitigated these effects (e.g., anxiety: 25.3%; OR = 0.26). Compared to the Radiologist Only scenario, the AI Flagged + explanation scenario showed only a modest increase in anxiety (p = 0.04) and no significant trust reduction (p = 0.42). AI approval remained high (> 85%) across all groups.

conclusionDisclosing discordant AI results reduces trust and increases anxiety, second-opinion intent, and legal concerns. Contextualised disclosure of AI results mitigates adverse emotional and behavioural responses, supporting its use as a communication strategy in AI-integrated mammography. KEY POINTS: Question Current guidelines lack clear recommendations on disclosing AI-generated mammography findings, creating uncertainty about patient trust, anxiety, and medicolegal implications of discordant results. Findings Disclosing discordant AI mammography findings reduced patient trust, increased anxiety, second-opinion seeking, and litigation intent; adding contextual explanations significantly mitigated these adverse effects. Clinical relevance Providing clear context about AI limitations in mammography reports mitigates patient anxiety, enhances trust in radiologists, and reduces unnecessary follow-up and potential medicolegal actions, supporting optimal patient communication during clinical implementation of AI.

Indexed as

Artificial IntelligenceBreast NeoplasmsDisclosureImage Interpretation, Computer-AssistedMammographyAgedAnxietyCross-Sectional StudiesFemaleHumansItalyMiddle AgedPhysician-Patient RelationsSurveys and QuestionnairesTrustArtificial IntelligenceBreast cancer screeningcommunicationMammographyPatient trust

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.